Table 5.
Author | Year | Country | Subjects | Vitamin D (ng/ml) |
Positive CTD autoantibodies |
P valueh | Reference |
---|---|---|---|---|---|---|---|
Ritterhouse L. et al. | 2011 | USA | 32 SLE, 32 CTRLa |
17.3 vs. 17.4^ vs. 29.4^^ |
ANA | <0.01 | [46] |
Szodoray P. et al. | 2011 | Hungary | 177 SLE (160 females, 17 males) | <15 vs. 15–30 vs. ≥ 30 |
anti-dsDNA | 0.021 | [48] |
Costenbader K.H. et al. | 2008 | Boston, USA | 190 SLE | NR | Risk of SLE | NS | [49] |
Bonakdar Z.S. et al. | 2011 | Iran | 40 SLEb | 25–39.9 vs. 12.5–24.9 vs. <12.5 nmol/l |
anti-dsDNA | <0.001 | [50] |
Mok C.C. et al. | 2012 | China | 290 SLEc | <30 vs. < 15 | anti-dsDNA, anti-C1q |
0.02 0.02 |
[51] |
Thudi A. et al. | 2008 | Texas, USA | 37 SLE | >47 nmol/l vs. <47 nmol/l |
anti-dsDNA | 0.0069 | [52] |
AlSaleem A. et al. | 2015 | Saudi Arabia | 28 SLE children (26 female, 2 male) | 51.1 ± 33.6 | anti-dsDNA, ANA |
NS NS |
[53] |
Muller K. et al. | 1990 | Denmark | 35 Sjogren | 28.2 ± 12.4 | IgM RF, IgA RF |
<0.05 NS |
[54] |
Hajas A. et al. | 2015 | Hungary | 125 MCTD, 48 CTRLd |
26.16 ± 13.5 | anti-U1-RNP, anti-CL IgA |
0.022 0.015 |
[55] |
Zold E. et al. | 2008 | Hungary | 161 UCTD | NR; hypovitaminosis D | anti-U1-RNP, anti-SSA, anti-CCP |
0.024 0.029 0.0001 |
[56] |
Paupitz J.A. et al. | 2010 | Brazil | 23 APSe, 23 CTRLf |
21.64 ± 11.26 vs. 28.59 ± 10.67 mg/dl |
IgG anti-CL IgM anti-CL |
0.222 0.535 |
[57] |
Arnson Y. et al. | 2011 | Israel | 327 SSc, 141 CTRLg |
18.2 ± 13.2 12.7 ± 6.6 16.8 ± 12.3 |
ANA, Anti-SCL70, RF |
NS NS <0.001 |
[58] |
SLE = Systemic lupus erythematosus; ANA = Antinuclear antibodies; anti-dsDNA = Anti-double stranded DNA antibodies; APS = Antiphospholipid syndrome; PV = Pemphigus vulgaris; IgM RF = IgM rheumatoid factor; IgA RF = IgA rheumatoid factor; anti-CL IgA = anti-cardiolipin IgA; RNP = ribonucleoprotein; anti-SSA = anti-Sjögren's-syndrome-related antigen A; anti-CCP = Anti-cyclic citrullinated peptide antibody; SSc = Systemic sclerosis; anti-SCL70 = anti-topoisomerase I; RF = Rheumatoid factor
aHealthy matched controls; n=14 ANA-positive^, n=18 ANA-negative^^
b5 mild vitamin D deficiency, 25 moderate vitamin D deficiency, 7 severe vitamin D deficiency
c277 vitamin D insufficiency (<30 ng/ml), 77 vitamin D deficiency (<10 ng/ml)
dage- and sex-matched healthy controls
epre-menopausal women
fage- and race-matched healthy controls
ghealthy controls
hCorrelation between vitamin D levels and positive CTD antibodies